← Back to all funds
Astorg
Submit feedbackPrivate EquityBusiness ServicesTechnologyHealthcareIndustrialMedia & EducationFood & AgricultureReal Estate & Construction
Independent since its 1998 spinoff from Suez, this firm applies a thematic approach to back global B2B niche leaders. Recent activity includes the divestment of clinical trial technology provider Clario to Thermo Fisher.
€8.1B
AUM
16
Funds
80
Executives
Investment Profile
Investment Range
€50M - €500M
Focus
Buy Out, Growth Capital
Geographies
Europe, North America
Assets (4 of 68)
2
Industrial Manufacturing
1
Agriculture
1
Business Services
Showing 1–4 of 4 assets